Abstract Details
|
Nassim Naderi, MD
(Medsurant monitoring)
PRESENTER |
No disclosure on file |
| Jeff Guptill, MD, FAAN (argenx US) | Dr. Guptill has received personal compensation for serving as an employee of argenx. Dr. Guptill has or had stock in argenx. |
| No disclosure on file | |
| Jack J. Lin, MD (UC Irvine Medical Center) | Dr. Lin has received stock or an ownership interest from StimScience. Dr. Lin has received stock or an ownership interest from IFovea. |
| Mona Sazgar, MD (University of California, Irvine) | Dr. Sazgar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Sazgar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xenon. Dr. Sazgar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Sazgar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis. Dr. Sazgar has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eisai. Dr. Sazgar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Lifesciences. The institution of Dr. Sazgar has received research support from UCB. Dr. Sazgar has received publishing royalties from a publication relating to health care. |
| Indranil Sen-Gupta, MD | Dr. Sen-Gupta has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global Advisors. |
| Lilit Mnatsakanyan, MD (UC Irvine Medical Center) | Dr. Mnatsakanyan has nothing to disclose. |